Incyte is working alongside a company that promises to use artificial intelligence to "redefine" how biotech companies discover small molecule medicines.
Incyte's drug Zynyz has become the first treatment specifically approved by the FDA for first-line anal cancer - four years after it was rejected by the regulators.
Federal regulators have approved Capital One Financial Corporation’s acquisition of Discover Financial Services, clearing the final regulatory hurdle of the $35 billion deal.
Artesian Resources, one of the few public companies in Delaware, quietly changed leadership to the fifth generation of the Taylor family earlier this year.
DuPont has now named five directors to the board of its rising electronics company, a little more than a week since the company has named longtime executive Jon Kemp as its CEO.
DuPont's stock rose in the day after the materials technology conglomerate announced it will retain its water division but will spin off its electronics division by November 2025.
